Liver Diseases  >>  Avastin (bevacizumab)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Avastin (bevacizumab) / Roche
AVAMET, NCT01493713 / 2011-000143-24: Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer

Completed
4
83
Europe
Evaluate the correlation of overall different objective response.
Grupo Espanol Multidisciplinario del Cancer Digestivo
Colorectal Cancer, Hepatic Metastasis
12/14
12/17

Download Options